Mesoblast has an extremely valuable suite of drugs that...

Mesoblast has an extremely valuable suite of drugs that completed phase 3 trials with extremely good results, sure they failed the FDA approval process but that doesn't mean that they don't work. All drugs that Mesoblast trialled worked, so they are very valuable to any of the major pharmaceutical companies around the globe. The research gained, along with the knowledge just ads to the drug suite of I.P. that can be sold off for potentially millions of dollars or even billions for that matter. At any moment from this point forward a major pharmaceutical company could swallow up Mesoblast and offer shareholders something major of value. It would be impossible to know how much each share of MSB is worth but we could be looking at $10+ just based on what we have achieved so far. Remember multiple drugs at phase 3 is worth a lot, just imagine what a major pharmaceutical company could do with this.